Case report: Uterus sarcoma associated with a microangiopathic hemolytic anemia. A review

被引：5

作者：

Tsatsaris, V

Lotz, JP

Parrot, A

Andre, T

Lafont, B

Bouleuc, C

Antoine, M

Izrael, V

机构：

来源：

REVUE DE MEDECINE INTERNE | 1996年 / 17卷 / 09期

关键词：

metastatic sarcoma; microangiopathic hemolytic anemia; chemotherapy; intra alveolar hemorrhage; hemolytic anemia;

D O I：

10.1016/0248-8663(96)83703-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Microangiopathic hemolytic anemia (MAHA) is a rare but severe complication of neoplastic disease. The diagnosis of thrombotic microangiopathy is based on a triad of a hemolytic anemia with schistocytes, thrombocytopenia, and renal failure. Carcinoma-associated MAHA and chemotherapeutic-induced MAHA have been described. Because of differences concerning prognosis and treatment it is important for the clinician io distinguish these two syndromes. However, to our knowledge, this is the first case of a sarcoma-associated thrombotic microangiopathy.

引用

收藏

页码：749 / 753

页数：5

相关论文

共 25 条

[1] HEMOLYTIC UREMIC SYNDROME ASSOCIATED WITH NEOADJUVANT CHEMOTHERAPY IN THE TREATMENT OF ADVANCED CERVICAL-CANCER [J].

ANGIOLA, G ;

BLOSS, JD ;

DISAIA, PJ ;

WARNER, AS ;

MANETTA, A ;

BERMAN, ML .

GYNECOLOGIC ONCOLOGY, 1990, 39 (02) :214-217

[2] MICRO-ANGIOPATHIC HEMOLYTIC-ANEMIA AND CANCER - REVIEW [J].

ANTMAN, KH ;

SKARIN, AT ;

MAYER, RJ ;

HARGREAVES, HK ;

CANELLOS, GP .

MEDICINE, 1979, 58 (05) :377-384

[3] THROMBOTIC THROMBOCYTOPENIC PURPURA [J].

BELL, W .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (01) :91-93

[4] IMPROVED SURVIVAL IN THROMBOTIC THROMBOCYTOPENIC PURPURA HEMOLYTIC UREMIC SYNDROME - CLINICAL-EXPERIENCE IN 108 PATIENTS [J].

BELL, WR ;

BRAINE, HG ;

NESS, PM ;

KICKLER, TS .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (06) :398-403

[5] ADVERSE HEMATOLOGICAL COMPLICATIONS OF ANTICANCER DRUGS - CLINICAL PRESENTATION, MANAGEMENT AND AVOIDANCE [J].

BODENSTEINER, DC ;

DOOLITTLE, GC .

DRUG SAFETY, 1993, 8 (03) :213-224

[6] PLASMAPHERESIS AND ANTIPLATELET AGENTS IN THE TREATMENT OF THE HEMOLYTIC UREMIC SYNDROME SECONDARY TO MITOMYCIN [J].

CHOW, S ;

ROSCOE, J ;

CATTRAN, DC .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1986, 7 (05) :407-412

[7]

CLAYCOMB CL, 1986, J AM OSTEOPATH ASSOC, V8, P499

[8] VASCULAR TOXICITY ASSOCIATED WITH ANTINEOPLASTIC AGENTS [J].

DOLL, DC ;

RINGENBERG, QS ;

YARBRO, JW .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (09) :1405-1417

[9] BLEEDING AND INTRAVASCULAR CLOTTING IN MALIGNANCY - REVIEW [J].

GOODNIGHT, SH .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1974, 230 (MAR18) :271-288

[10]

GRADISHAR WJ, 1990, CANCER, V66, P1914, DOI 10.1002/1097-0142(19901101)66:9<1914::AID-CNCR2820660910>3.0.CO